Oxford BioMedica

2 followers

‌

Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.

Industries

Biotechnology

Headquarters

England, United Kingdom

Employees

501-1,000

Links

Org chart

Frank Mathias

CEO

Frank Mathias

Collapse

Kyriacos Mitrophanous

Chief Scientific Officer

Lisa James

Chief People Officer

Sébastien Ribault

Chief Commercial Officer

Natalie Walter

General Counsel

Mark Caswell

Site Head of US Operations

Michelle Robins

Vp, Information Systems

Alison Roe

Head Of Client Programme Management

Thierry Cournez

Chief Operating Officer

Simon Simpkins

Vp, Head Of Analytical Development And QC

Aziz Kagdi Mba, Cmgr Fcmi

Operations Programme Director

Fiona Forsyth (née Sandeman)

Director Clinical Operations

Aurélie Charpentier

Director Of Business Development

Mark Marrano

Director, Business Development

Sandrine Lopes

Senior Director, Head Of Business Development EMEA

Lucinda Crabtree

Chief Financial Officer

Board & advisors

Stuart Henderson

Deputy Chair & Senior Independent Non-Executive Director

Heather Preston

Independent Non-Executive Director

Martin Diggle

Non-Executive Director

Robert Ghenchev

Non-Executive Director

Dame Kay Davies

Senior Independent Director

Catherine Moukheibir

Independent Non-Executive Director

Namrata P Patel

Independent Non-Executive Director

Michael Hayden

Non-Executive Director

Teams

+75

Scientific Research and Development

78 members

+17

Leadership Team

20 members

Legal and Compliance

9 members

Human Resources and Talent Management

6 members

Offices

Similar companies

Ionis Pharmaceuticals

29 followers

Exelixis

13 followers

Ultragenyx Pharmaceutical

10 followers

Ascendis Pharma

9 followers

United Therapeutics

8 followers

NeoGenomics

9 followers

Neurocrine Biosciences

7 followers

Veracyte

4 followers

Atara Biotherapeutics

4 followers

Novocure

3 followers

Adaptive Biotechnologies

14 followers

Explore companies